Pub Date : 2023-05-17DOI: 10.24018/ejmed.2023.5.3.1746
B. Eze
Intravesical prostatic protrusion (IPP) can predict disease progression and development of complications in benign prostatic hyperplasia (BPH). The aim was to determine if IPP at initial evaluation can predict need for surgical therapy in BPH patients. A retrospective study of BPH patients at ESUT Teaching Hospital, Enugu. Patients were involved in a previous prospective study in which they had abdominal ultrasonography measurement of IPP and prostate volume (TPV). IPP was measured in millimeter and divided into < 10 mm and ≥ 10 mm. The clinicians were blinded about the patients’ IPP while making decision for therapy. After at least a 24-month follow up period, biodata, IPP, TPV, IPSS and therapy given/recommended were retrieved and analyzed. The odds ratio of having/awaiting surgery at IPP cut-off of 10 millimeters was calculated. P < 0.05 was considered significant. One hundred patients’ records were reviewed. Forty-four patients (44%) were still on medical therapy, 20 (20%) were awaiting surgery and 36 (36%) had prostatectomy. Eight (19.05%) of 42 patients with IPP < 10 mm had or were recommended for surgical therapy while 48 (82.76%) of 58 patients with IPP ≥ 10 mm had or were recommended for surgical therapy (p=0.000). There was a statistically significant odd for surgical therapy when IPP at initial evaluation was ≥ 10mm (OR=20.40, 95% CI [7.30,57.04]). IPP at initial evaluation ≥ 10 mm is a significant predictor of needing surgical therapy in BPH patients.
{"title":"Intravesical Prostatic Protrusion as A Predictor of Need for Surgical Therapy in Benign Prostatic Hyperplasia Patients","authors":"B. Eze","doi":"10.24018/ejmed.2023.5.3.1746","DOIUrl":"https://doi.org/10.24018/ejmed.2023.5.3.1746","url":null,"abstract":"\u0000Intravesical prostatic protrusion (IPP) can predict disease progression and development of complications in benign prostatic hyperplasia (BPH). The aim was to determine if IPP at initial evaluation can predict need for surgical therapy in BPH patients. A retrospective study of BPH patients at ESUT Teaching Hospital, Enugu. Patients were involved in a previous prospective study in which they had abdominal ultrasonography measurement of IPP and prostate volume (TPV). IPP was measured in millimeter and divided into < 10 mm and ≥ 10 mm. The clinicians were blinded about the patients’ IPP while making decision for therapy. After at least a 24-month follow up period, biodata, IPP, TPV, IPSS and therapy given/recommended were retrieved and analyzed. The odds ratio of having/awaiting surgery at IPP cut-off of 10 millimeters was calculated. P < 0.05 was considered significant. One hundred patients’ records were reviewed. Forty-four patients (44%) were still on medical therapy, 20 (20%) were awaiting surgery and 36 (36%) had prostatectomy. Eight (19.05%) of 42 patients with IPP < 10 mm had or were recommended for surgical therapy while 48 (82.76%) of 58 patients with IPP ≥ 10 mm had or were recommended for surgical therapy (p=0.000). There was a statistically significant odd for surgical therapy when IPP at initial evaluation was ≥ 10mm (OR=20.40, 95% CI [7.30,57.04]). IPP at initial evaluation ≥ 10 mm is a significant predictor of needing surgical therapy in BPH patients.\u0000","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128401801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-17DOI: 10.24018/ejmed.2023.5.3.1689
Agnes Indah Nugraheni, Ida Ayu Ratih Wulansari Manuaba, Ida Bagus Putera Manuaba
Hemorrhage of corpus luteum is a rare condition in women of reproductive age. It is possible for a woman's corpus luteum to have asymptomatic hemorrhaging as a result of blood vessel penetration through the wall of the corpus luteum during the second half of her menstrual cycle. There have been very few occurrences of it growing to be too large and then rupturing. Those who suffer from polycystic ovarian syndrome (PCOS) are at risk for developing this condition. Polycystic ovarian syndrome is characterized by an inflammation of the body's hormonal function, which results in the development of larger ovaries that also include a number of small follicular cysts. The development of cysts on the ovaries, which contribute to the appearance of larger ovaries, is brought on by an abundance of androgen hormones in the body. In a minority of cases, this enlargement also has the potential to rupture, which is an additional concern. The predominant symptom that presented clinically was sharp pain in the lower abdomen. Because to the fact that HCL may present similarly to other conditions, diagnosis might be difficult. We present and discuss three cases of young female patients who presented with acute abdominal pain, large-volume of hemoperitoneum, and anemia. Laparoscopic examination in each case showed a hemorrhagic corpus luteal cyst.
{"title":"Acute Abdominal Pain Caused by Hemorrhagic Corpus Lutheum in Reproductive-Aged Women: A Case Series","authors":"Agnes Indah Nugraheni, Ida Ayu Ratih Wulansari Manuaba, Ida Bagus Putera Manuaba","doi":"10.24018/ejmed.2023.5.3.1689","DOIUrl":"https://doi.org/10.24018/ejmed.2023.5.3.1689","url":null,"abstract":"\u0000Hemorrhage of corpus luteum is a rare condition in women of reproductive age. It is possible for a woman's corpus luteum to have asymptomatic hemorrhaging as a result of blood vessel penetration through the wall of the corpus luteum during the second half of her menstrual cycle. There have been very few occurrences of it growing to be too large and then rupturing. Those who suffer from polycystic ovarian syndrome (PCOS) are at risk for developing this condition. Polycystic ovarian syndrome is characterized by an inflammation of the body's hormonal function, which results in the development of larger ovaries that also include a number of small follicular cysts. The development of cysts on the ovaries, which contribute to the appearance of larger ovaries, is brought on by an abundance of androgen hormones in the body. In a minority of cases, this enlargement also has the potential to rupture, which is an additional concern. The predominant symptom that presented clinically was sharp pain in the lower abdomen. Because to the fact that HCL may present similarly to other conditions, diagnosis might be difficult. We present and discuss three cases of young female patients who presented with acute abdominal pain, large-volume of hemoperitoneum, and anemia. Laparoscopic examination in each case showed a hemorrhagic corpus luteal cyst.\u0000","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"70 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126044128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-17DOI: 10.24018/ejmed.2023.5.3.1284
I. G. S. Winata, W. A. Setiawan, Jonathan Adrian, Gede Odi Bayu Dharma Perkasa, J. Roxanne
Assessing the fetal heart rate (FHR) is one of the most important aspects of antenatal care and delivery. Fetal heart rate is one indicator of fetal well-being. Assessing FHR can be done by auscultation or by using a cardiotocography (KTG) device, also known as an Electronic Fetal Monitor (EFM). In interpreting the results of the cardiotocography examination, there are two criteria used to interpret the condition of the fetus, namely the criteria issued by the International Federation of Gynecology and Obstetrics (FIGO) and the National Institute of Child Health and Human Development (NICHD).
{"title":"Comparison between Figo and Nichd Criteria in Assessing Fetal Heart Rate","authors":"I. G. S. Winata, W. A. Setiawan, Jonathan Adrian, Gede Odi Bayu Dharma Perkasa, J. Roxanne","doi":"10.24018/ejmed.2023.5.3.1284","DOIUrl":"https://doi.org/10.24018/ejmed.2023.5.3.1284","url":null,"abstract":"Assessing the fetal heart rate (FHR) is one of the most important aspects of antenatal care and delivery. Fetal heart rate is one indicator of fetal well-being. Assessing FHR can be done by auscultation or by using a cardiotocography (KTG) device, also known as an Electronic Fetal Monitor (EFM). In interpreting the results of the cardiotocography examination, there are two criteria used to interpret the condition of the fetus, namely the criteria issued by the International Federation of Gynecology and Obstetrics (FIGO) and the National Institute of Child Health and Human Development (NICHD).","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121062901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-06DOI: 10.34104/ejmhs.023.054062
Ionizing radiation gives immense benefit to the patient in the hospital through diagnostic and therapeutic procedures but unnecessary radiation may cause short- and long-term trouble to healthcare workers & public. The purpose of the study is to monitor the real-time radiation in the Mymensingh Medical College Hospital (MMCH) Campus of Bangladesh and assessment of radiological risks to healthcare workers & public. Real-time radiation monitoring was accomplished in the MMCH campus from August-September 2022 using digital portable radiation monitoring devices through the In-Situ technique. The real-time radiation dose rates & calculated annual effective doses to healthcare workers and the public ranged from 0.25-4.11 µSv/hr (mean: 1.438 ± 0.331 μSv/h) and 0.438-8.585 mSv (mean: 2.529 ± 0.627 mSv) respectively. The excess lifetime cancer risk (ELCR) among healthcare worker & public on the MMCH campus were estimated based on the annual effective dose and ranged from 8.436 × 10-3 to 16.572 × 10-3 (mean: 10.667 × 10-3). The mean ELCR in the MMCH campus is higher than that of the worldwide average value. Real-time radiation monitoring in the big hospital campus is vital for detecting a malfunction of the radiation-generating equipment and wrong handling of the radioactive substance. The study would help for minimizing the radiological risk to healthcare workers & public in the big hospital campus, thereby would ensure the hospital’s environment is free from radioactive contamination.
{"title":"Estimation of Radiological Risk on Healthcare Workers and Public in Mymensingh Medical College Hospital Campus, Bangladesh","authors":"","doi":"10.34104/ejmhs.023.054062","DOIUrl":"https://doi.org/10.34104/ejmhs.023.054062","url":null,"abstract":"Ionizing radiation gives immense benefit to the patient in the hospital through diagnostic and therapeutic procedures but unnecessary radiation may cause short- and long-term trouble to healthcare workers & public. The purpose of the study is to monitor the real-time radiation in the Mymensingh Medical College Hospital (MMCH) Campus of Bangladesh and assessment of radiological risks to healthcare workers & public. Real-time radiation monitoring was accomplished in the MMCH campus from August-September 2022 using digital portable radiation monitoring devices through the In-Situ technique. The real-time radiation dose rates & calculated annual effective doses to healthcare workers and the public ranged from 0.25-4.11 µSv/hr (mean: 1.438 ± 0.331 μSv/h) and 0.438-8.585 mSv (mean: 2.529 ± 0.627 mSv) respectively. The excess lifetime cancer risk (ELCR) among healthcare worker & public on the MMCH campus were estimated based on the annual effective dose and ranged from 8.436 × 10-3 to 16.572 × 10-3 (mean: 10.667 × 10-3). The mean ELCR in the MMCH campus is higher than that of the worldwide average value. Real-time radiation monitoring in the big hospital campus is vital for detecting a malfunction of the radiation-generating equipment and wrong handling of the radioactive substance. The study would help for minimizing the radiological risk to healthcare workers & public in the big hospital campus, thereby would ensure the hospital’s environment is free from radioactive contamination.","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121193834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-05DOI: 10.34104/ejmhs.023.047053
Rabies remains a public health problem since ancient times and kills at least 59,000 annually, almost all transmitted via dog bites. It creates considerable economic impacts on developing countries, primarily in Africa and Asia. The World Health Organization has launched the elimination of rabies, as a global goal in the reduction of human rabies prevalence to zero cases by the end of 2030. Several countries, in Western Europe and North America, have adopted an elimination strategy for controlling rabies and have achieved elimination in the domestic dog population. The goal of elimination of rabies is achievable and would require substantial resources addressing this global health problem on individuals and health authorities, following WHO guidelines on the mass vaccination of dogs as well as increasing public awareness about rabies and its epidemiology.
{"title":"Ending Rabies as an Epidemiologic and Global Public Health Problem","authors":"","doi":"10.34104/ejmhs.023.047053","DOIUrl":"https://doi.org/10.34104/ejmhs.023.047053","url":null,"abstract":"Rabies remains a public health problem since ancient times and kills at least 59,000 annually, almost all transmitted via dog bites. It creates considerable economic impacts on developing countries, primarily in Africa and Asia. The World Health Organization has launched the elimination of rabies, as a global goal in the reduction of human rabies prevalence to zero cases by the end of 2030. Several countries, in Western Europe and North America, have adopted an elimination strategy for controlling rabies and have achieved elimination in the domestic dog population. The goal of elimination of rabies is achievable and would require substantial resources addressing this global health problem on individuals and health authorities, following WHO guidelines on the mass vaccination of dogs as well as increasing public awareness about rabies and its epidemiology.","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117168704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-05DOI: 10.24018/ejmed.2023.5.3.1532
Emily Machuma Walumbe Wamalwa
SARS-CoV-2 virus is the major cause of viral disease, COVID-19 which is highly infectious, WHO did its roll out for coordination, policy and technical guidance. About 64.5% of the population globally have had one dose of COVID-19 vaccine. Close to vaccines have been administered with 18.3 million daily. In low middle Countries, approximately 14.5% have received atleast a single dose. A number of researches have come up with vaccines to curb COVID-19 disease. A researches conducted among the exposed people -60 years and above, who are frontline workers, health care workers, persons with comorbidities. Different researches have been carried out in different cities like Quantitative data presented descriptively and qualitative, thematically. A number of factors dictated the willingness to take up the vaccine, these included confidence in the vaccine, more than personal factors of participants. The respondents revealed mistrust from most people both in developed and non-developed countries, believe in God’s protection and ignorance in vaccine development. On the other hand, peer pressure and effectiveness of the vaccination programmes among childhood diseases contributed to low uptake of the vaccine. Conclusion: attention ought to be given to factors promoting vaccine uptake and misconceptions should be expelled concerning the disease. Recommendations: Strengthen disease surveillance at all stages and regularly updating of COVID-19 data to national level by vaccinating counties, Counties are required to increase researches on more about the disease, use COVID-19 data for decision making in terms of curbing the disease and give refresher course on health care workers surveillance.
{"title":"COVID-19 Vaccination Uptake in Kenya","authors":"Emily Machuma Walumbe Wamalwa","doi":"10.24018/ejmed.2023.5.3.1532","DOIUrl":"https://doi.org/10.24018/ejmed.2023.5.3.1532","url":null,"abstract":"\u0000SARS-CoV-2 virus is the major cause of viral disease, COVID-19 which is highly infectious, WHO did its roll out for coordination, policy and technical guidance. About 64.5% of the population globally have had one dose of COVID-19 vaccine. Close to vaccines have been administered with 18.3 million daily. In low middle Countries, approximately 14.5% have received atleast a single dose. A number of researches have come up with vaccines to curb COVID-19 disease. A researches conducted among the exposed people -60 years and above, who are frontline workers, health care workers, persons with comorbidities. Different researches have been carried out in different cities like Quantitative data presented descriptively and qualitative, thematically. A number of factors dictated the willingness to take up the vaccine, these included confidence in the vaccine, more than personal factors of participants. The respondents revealed mistrust from most people both in developed and non-developed countries, believe in God’s protection and ignorance in vaccine development. On the other hand, peer pressure and effectiveness of the vaccination programmes among childhood diseases contributed to low uptake of the vaccine. \u0000\u0000\u0000Conclusion: attention ought to be given to factors promoting vaccine uptake and misconceptions should be expelled concerning the disease.\u0000\u0000\u0000Recommendations: Strengthen disease surveillance at all stages and regularly updating of COVID-19 data to national level by vaccinating counties, Counties are required to increase researches on more about the disease, use COVID-19 data for decision making in terms of curbing the disease and give refresher course on health care workers surveillance. \u0000","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"95 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115354171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-05DOI: 10.24018/ejmed.2023.5.3.1733
Nurci Efrilia Safitri Safitri
Trigeminal neuralgia is a facial pain syndrome that occurs repeatedly and chronically on one side of the face following the distribution of the trigeminal nerve branches. Trigeminal neuralgia is estimated to be around 0.16%-0.3%, with an incidence rate of 4-29 people per 100,000 people/year, with a higher incidence in women than men (ratio 3:2). The incidence rate increases with age. The causes of trigeminal neuralgia are divided into two types, classic and symptomatic. The main mechanism of trigeminal neuralgia is compression by the intracranial blood vessels which causes damage to the protective covering of the nerves or is known as the process of demyelination. Treatment of trigeminal neuralgia is pharmacotherapy, non-pharmacotherapy, surgery should be considered if treatment is ineffective, and preventive education.
{"title":"Trigeminal Neuralgia: A Brief Review","authors":"Nurci Efrilia Safitri Safitri","doi":"10.24018/ejmed.2023.5.3.1733","DOIUrl":"https://doi.org/10.24018/ejmed.2023.5.3.1733","url":null,"abstract":"\u0000\u0000Trigeminal neuralgia is a facial pain syndrome that occurs repeatedly and chronically on one side of the face following the distribution of the trigeminal nerve branches. Trigeminal neuralgia is estimated to be around 0.16%-0.3%, with an incidence rate of 4-29 people per 100,000 people/year, with a higher incidence in women than men (ratio 3:2). The incidence rate increases with age. The causes of trigeminal neuralgia are divided into two types, classic and symptomatic. The main mechanism of trigeminal neuralgia is compression by the intracranial blood vessels which causes damage to the protective covering of the nerves or is known as the process of demyelination. Treatment of trigeminal neuralgia is pharmacotherapy, non-pharmacotherapy, surgery should be considered if treatment is ineffective, and preventive education. \u0000\u0000","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"396 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123261917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-02DOI: 10.24018/ejmed.2023.5.3.1697
S. Esmaeili, A. Zabeti
Background: Ocrelizumab is widely used as a Disease Modifying Drug (DMD) in Multiple sclerosis. The complete side effects are yet not known. Materials and Methods: We describe a 34-year-old female with longstanding relapsing-remitting Multiple Sclerosis for whom Ocrelizumab was started as an escalation therapy. She reported severe itchy and patchy lesions two months after the first full dose of Ocrelizumab. Pathohistological findings revealed the diagnosis of guttate psoriasis. Psoriasis continued to flare against treatment with topical steroids, and UV therapy and progressed to developed arthritis psoriasis. Results: Treatment escalated to an IL-17 antagonist (Secukinumab), with a favorable outcome. Ocrelizumab was discontinued. After one year of follow-up, the patient remained stable from an MS standpoint. Conclusion: This is the third report showing the possible cutaneous side effect of Ocrelizumab.
{"title":"Ocrelizumab-induced Psoriasis in A Patient with Relapsing-Remitting Multiple Sclerosis","authors":"S. Esmaeili, A. Zabeti","doi":"10.24018/ejmed.2023.5.3.1697","DOIUrl":"https://doi.org/10.24018/ejmed.2023.5.3.1697","url":null,"abstract":"\u0000Background: Ocrelizumab is widely used as a Disease Modifying Drug (DMD) in Multiple sclerosis. The complete side effects are yet not known.\u0000\u0000\u0000Materials and Methods: We describe a 34-year-old female with longstanding relapsing-remitting Multiple Sclerosis for whom Ocrelizumab was started as an escalation therapy. She reported severe itchy and patchy lesions two months after the first full dose of Ocrelizumab. Pathohistological findings revealed the diagnosis of guttate psoriasis. Psoriasis continued to flare against treatment with topical steroids, and UV therapy and progressed to developed arthritis psoriasis. \u0000\u0000\u0000Results: Treatment escalated to an IL-17 antagonist (Secukinumab), with a favorable outcome. Ocrelizumab was discontinued. After one year of follow-up, the patient remained stable from an MS standpoint. \u0000\u0000\u0000Conclusion: This is the third report showing the possible cutaneous side effect of Ocrelizumab. \u0000","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125029497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-01DOI: 10.34104/ejmhs.023.039046
Maternal mortality (MM) is unacceptably high in many parts of the world, including Sudan, despite the effort to reduce it. This paper will review MM in Elgadarif State in Sudan and how to improve obstetric care quality. This is a hospital- and community-based prospective research study of MM by counting every MD (MD) in the state that has occurred in Elgadaref State, Sudan, during the study period. The state and central offices are notified of the data collected with respect to MD. An expert reviews every MD in a hospital. The investigator looks into every MD in the community. There were 72 MDs; 68 cases were avoidable, while four were unavoidable. The MMR was 176/100000/ live births. Significant factors associated with MM are gestational age, the direct cause of death, existing medical problems and co-morbidities, shortage of antenatal care services, lack of delivery services, and preterm labor (p-value <0.05). Most women who died in this study were hospitalized seriously ill (85.7%) or at home (10.7%). The common cause of MD is postpartum haemorrhage19 (26.5%). In this area, there is a considerable contribution of the Kalazar 6 (8.5%). Poorly financed and weak referral systems are critical determinants of maternity outcomes. Other determinants include poor access, equity of services, lack of skilled birth attendance, protocols, and essential drug availability. Maternal Mortality Review provides a valuable opportunity to learn from each maternal death and take action to prevent future deaths. By prioritizing safe motherhood and investing in maternal health services, we can ensure that all women have access to the care they need during pregnancy and childbirth.
{"title":"Maternal Mortality Review, an Open Window on the Experience of Safe Motherhood in Low-Resource Countries","authors":"","doi":"10.34104/ejmhs.023.039046","DOIUrl":"https://doi.org/10.34104/ejmhs.023.039046","url":null,"abstract":"Maternal mortality (MM) is unacceptably high in many parts of the world, including Sudan, despite the effort to reduce it. This paper will review MM in Elgadarif State in Sudan and how to improve obstetric care quality. This is a hospital- and community-based prospective research study of MM by counting every MD (MD) in the state that has occurred in Elgadaref State, Sudan, during the study period. The state and central offices are notified of the data collected with respect to MD. An expert reviews every MD in a hospital. The investigator looks into every MD in the community. There were 72 MDs; 68 cases were avoidable, while four were unavoidable. The MMR was 176/100000/ live births. Significant factors associated with MM are gestational age, the direct cause of death, existing medical problems and co-morbidities, shortage of antenatal care services, lack of delivery services, and preterm labor (p-value <0.05). Most women who died in this study were hospitalized seriously ill (85.7%) or at home (10.7%). The common cause of MD is postpartum haemorrhage19 (26.5%). In this area, there is a considerable contribution of the Kalazar 6 (8.5%). Poorly financed and weak referral systems are critical determinants of maternity outcomes. Other determinants include poor access, equity of services, lack of skilled birth attendance, protocols, and essential drug availability. Maternal Mortality Review provides a valuable opportunity to learn from each maternal death and take action to prevent future deaths. By prioritizing safe motherhood and investing in maternal health services, we can ensure that all women have access to the care they need during pregnancy and childbirth.","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"45 7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131171974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-29DOI: 10.34104/ejmhs.023.026038
This paper aims to explore the perception of precision medicine (PM) and pharmacogenomics (PGx) among undergraduate and graduate students in Bangladesh. A cross-sectional survey was conducted among students from different universities across the country. The results of the survey showed that the majority of students had a positive attitude towards precision medicine and pharmacogenomics, perceiving it as a means to improve diagnosis and treatment accuracy. Furthermore, the majority of students also expressed a willingness to learn more about precision medicine and pharmacogenomics, suggesting that there is potential for these practices to be utilized in Bangladesh. Particularly in this study, 337 students from life science and relevant programs participated. The results of our study showed that 84% of graduate students and 74% of undergraduate students thought PM was a promising healthcare model. In addition, 39% of students are highly encouraged to pursue their post-graduation in the subject areas of PGx and PM in order to support patients. The majority (62%) thought that patient privacy was the ethical concern most closely related to pharmacogenomic testing, while 19% of respondents thought that data confidentiality was the key issue. The findings of this study provide insight into the potential of precision medicine and pharmacogenomics in Bangladesh and suggest that further research into the attitudes of healthcare professionals should be conducted in order to take full advantage of the potential of these practices.
{"title":"Exploring the Attitudes, Beliefs and Perceptions of Undergraduate and Graduate Students in Bangladesh towards Precision Medicine and Pharmacogenomics Practice: A Qualitative Study","authors":"","doi":"10.34104/ejmhs.023.026038","DOIUrl":"https://doi.org/10.34104/ejmhs.023.026038","url":null,"abstract":"This paper aims to explore the perception of precision medicine (PM) and pharmacogenomics (PGx) among undergraduate and graduate students in Bangladesh. A cross-sectional survey was conducted among students from different universities across the country. The results of the survey showed that the majority of students had a positive attitude towards precision medicine and pharmacogenomics, perceiving it as a means to improve diagnosis and treatment accuracy. Furthermore, the majority of students also expressed a willingness to learn more about precision medicine and pharmacogenomics, suggesting that there is potential for these practices to be utilized in Bangladesh. Particularly in this study, 337 students from life science and relevant programs participated. The results of our study showed that 84% of graduate students and 74% of undergraduate students thought PM was a promising healthcare model. In addition, 39% of students are highly encouraged to pursue their post-graduation in the subject areas of PGx and PM in order to support patients. The majority (62%) thought that patient privacy was the ethical concern most closely related to pharmacogenomic testing, while 19% of respondents thought that data confidentiality was the key issue. The findings of this study provide insight into the potential of precision medicine and pharmacogenomics in Bangladesh and suggest that further research into the attitudes of healthcare professionals should be conducted in order to take full advantage of the potential of these practices.","PeriodicalId":113708,"journal":{"name":"European Journal of Medical and Health Sciences","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128346897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：